Groupe Bruxelles Lambert Crecimiento futuro

Future controles de criterios 3/6

Se prevé que los ingresos de Groupe Bruxelles Lambert disminuyan en un 18.3% al año, mientras que se espera que sus beneficios anuales crezcan en un 36% al año. Se prevé que el BPA crezca en un 35.6% anual. Se prevé que la rentabilidad financiera sea de 3.4% en 3 años.

Información clave

36.0%

Tasa de crecimiento de los beneficios

35.6%

Tasa de crecimiento del BPA

Crecimiento de los beneficios de Diversified Financial	-14.9%
Tasa de crecimiento de los ingresos	-18.3%
Rentabilidad financiera futura	3.4%
Cobertura de analistas	Low
Última actualización	08 Nov 2024

Actualizaciones recientes sobre el crecimiento futuro

Recent updates

Pinning Down Groupe Bruxelles Lambert SA's (EBR:GBLB) P/E Is Difficult Right Now

Nov 04

Is Now The Time To Put Groupe Bruxelles Lambert (EBR:GBLB) On Your Watchlist?

Sep 30

Subdued Growth No Barrier To Groupe Bruxelles Lambert SA's (EBR:GBLB) Price

Jun 08

Investors Appear Satisfied With Groupe Bruxelles Lambert SA's (EBR:GBLB) Prospects

Dec 18

Previsiones de crecimiento de beneficios e ingresos

ENXTBR:GBLB - Estimaciones futuras de los analistas y datos financieros pasados (EUR Millions)
Fecha	Ingresos	Beneficios	Flujo de caja libre	Flujo de caja operativo	Núm. de analistas medio
12/31/2026	4,223	494	N/A	N/A	1
12/31/2025	4,968	467	N/A	N/A	1
12/31/2024	5,845	469	N/A	N/A	1
9/30/2024	6,625	52	N/A	N/A	N/A
6/30/2024	6,776	326	290	846	N/A
3/31/2024	6,817	458	N/A	N/A	N/A
12/31/2023	6,750	368	466	1,122	N/A
9/30/2023	9,066	-40	N/A	N/A	N/A
6/30/2023	6,528	200	322	1,059	N/A
3/31/2023	8,321	-589	N/A	N/A	N/A
12/31/2022	5,425	-292	184	819	N/A
9/30/2022	8,169	-523	N/A	N/A	N/A
6/30/2022	5,452	-295	435	960	N/A
3/31/2022	7,873	-72	N/A	N/A	N/A
12/31/2021	6,956	211	588	1,041	N/A
9/30/2021	7,693	359	N/A	N/A	N/A
6/30/2021	7,339	341	774	1,121	N/A
3/31/2021	6,904	602	N/A	N/A	N/A
12/31/2020	6,598	391	870	1,230	N/A
9/30/2020	6,034	456	N/A	N/A	N/A
6/30/2020	5,926	684	887	1,318	N/A
3/31/2020	5,850	560	N/A	N/A	N/A
12/31/2019	5,747	705	661	1,064	N/A
9/30/2019	5,725	26	N/A	N/A	N/A
6/30/2019	5,686	-75	310	683	N/A
3/31/2019	5,703	-65	N/A	N/A	N/A
12/31/2018	5,586	-129	524	914	N/A
9/30/2018	5,795	524	N/A	N/A	N/A
6/30/2018	5,563	549	N/A	891	N/A
3/31/2018	5,616	586	N/A	N/A	N/A
12/31/2017	5,220	638	N/A	975	N/A
9/30/2017	5,595	990	N/A	N/A	N/A
6/30/2017	5,208	871	N/A	694	N/A
3/31/2017	3,962	698	N/A	N/A	N/A
12/31/2016	3,977	-458	N/A	551	N/A
9/30/2016	3,801	-679	N/A	N/A	N/A
6/30/2016	3,893	-582	N/A	1,000	N/A
3/31/2016	5,599	-42	N/A	N/A	N/A
12/31/2015	5,462	1,026	N/A	1,224	N/A
9/30/2015	5,241	1,040	N/A	N/A	N/A
6/30/2015	5,153	1,093	N/A	1,091	N/A
3/31/2015	4,969	967	N/A	N/A	N/A
12/31/2014	4,740	875	N/A	488	N/A
9/30/2014	4,865	1,036	N/A	N/A	N/A
6/30/2014	4,748	917	N/A	208	N/A
3/31/2014	4,380	750	N/A	N/A	N/A
12/31/2013	4,459	621	N/A	680	N/A

Previsiones de crecimiento futuro de los analistas

Ingresos vs. Tasa de ahorro: El pronóstico de crecimiento de los beneficios (36% al año) de GBLB es superior a la tasa de ahorro (1.4%).

Beneficios vs. Mercado: Se prevé que los beneficios (36% al año) de GBLB crezcan más rápidamente que el mercado Belgian (19.8% al año).

Beneficios de alto crecimiento: Se espera que los beneficios de GBLB crezcan significativamente en los próximos 3 años.

Ingresos vs. Mercado: Se prevé que los ingresos de GBLB disminuyan en los próximos 3 años (-18.3% al año).

Ingresos de alto crecimiento: Se prevé que los ingresos de GBLB disminuyan en los próximos 3 años (-18.3% al año).

Previsiones de crecimiento de los beneficios por acción

Rentabilidad financiera futura

ROE futura: Se prevé que la rentabilidad financiera de GBLB sea baja dentro de 3 años (3.4%).

Groupe Bruxelles Lambert Crecimiento futuro

Future controles de criterios 3/6

Información clave

Actualizaciones recientes sobre el crecimiento futuro

Price target decreased to €97.00

Consensus forecasts updated

Price target increased to €95.11

Analysts lower EPS estimates to €2.69

Recent updates

Third quarter 2024 earnings released: €1.61 loss per share (vs €0.35 profit in 3Q 2023)

Groupe Bruxelles Lambert SA to Report Nine Months, 2025 Results on Nov 06, 2025

Groupe Bruxelles Lambert SA to Report First Half, 2025 Results on Jul 31, 2025

Pinning Down Groupe Bruxelles Lambert SA's (EBR:GBLB) P/E Is Difficult Right Now

PE Firms Reportedly to Circle German Vitamin Supplement Maker Orthomol

Is Now The Time To Put Groupe Bruxelles Lambert (EBR:GBLB) On Your Watchlist?

Groupe Bruxelles Lambert SA to Report Fiscal Year 2024 Results on Mar 13, 2025

Second quarter 2024 earnings released: EPS: €0.67 (vs €1.53 in 2Q 2023)

Subdued Growth No Barrier To Groupe Bruxelles Lambert SA's (EBR:GBLB) Price

New major risk - Revenue and earnings growth

First quarter 2024 earnings released: EPS: €1.43 (vs €0.74 in 1Q 2023)

Upcoming dividend of €1.93 per share

New major risk - Revenue and earnings growth

Groupe Bruxelles Lambert SA to Report Q3, 2024 Results on Nov 07, 2024

Investors Appear Satisfied With Groupe Bruxelles Lambert SA's (EBR:GBLB) Prospects

Groupe Bruxelles Lambert SA to Report Q2, 2024 Results on Jul 31, 2024

Concentrix Corporation (NasdaqGS:CNXC) completed the acquisition of Webhelp SAS from Groupe Bruxelles Lambert SA (ENXTBR:GBLB), Marnix Luxembourg S.à R.l. and management of Webhelp.

Groupe Bruxelles Lambert SA to Report First Half, 2023 Results on Jul 31, 2023

Groupe Bruxelles Lambert SA to Report First Half, 2023 Results on Jul 31, 2023

Upcoming dividend of €1.93 per share at 3.5% yield

Full year 2022 earnings released

Price target decreased to €97.00

Third quarter 2022 earnings released

Second quarter 2022 earnings released: €1.38 loss per share (vs €0.72 profit in 2Q 2021)

First quarter 2022 earnings: Revenues exceed analysts expectations while EPS lags behind

Upcoming dividend of €1.93 per share

Groupe Bruxelles Lambert SA (ENXTBR:GBLB) signed an agreement to acquire an unknown majority stake in Sanoptis AG from Telemos Capital Limited.

Groupe Bruxelles Lambert SA (ENXTBR:GBLB) along with the management of Affidea has signed a definitive agreement to acquire a majority stake in Affidea B.V. from B-FLEXION Group for approximately €1 billion.

Gbl Reportedly Set to Buy Affidea

Full year 2021 earnings: EPS and revenues miss analyst expectations

Groupe Bruxelles Lambert Reportedly Considering A Bid to Take Ontex Group Private

Third quarter 2021 earnings released: €0.29 loss per share (vs €0.40 loss in 3Q 2020)

Second quarter 2021 earnings released: EPS €0.72 (vs €2.49 in 2Q 2020)

Here's Why We Think Groupe Bruxelles Lambert (EBR:GBLB) Is Well Worth Watching

Upcoming dividend of €1.75 per share

Consensus forecasts updated

Full year 2020 earnings released: EPS €2.53 (vs €4.49 in FY 2019)

Price target increased to €95.11

Did You Miss Groupe Bruxelles Lambert's (EBR:GBLB) 44% Share Price Gain?

New 90-day high: €86.02

Is Groupe Bruxelles Lambert SA (EBR:GBLB) A Risky Dividend Stock?

How Much Of Groupe Bruxelles Lambert SA (EBR:GBLB) Do Institutions Own?

Groupe Bruxelles Lambert SA, Annual General Meeting, Apr 27, 2021

New 90-day high: €83.74

New 90-day high: €83.00

Groupe Bruxelles Lambert SA (ENXTBR:GBLB), Future Shape LLC and Roman Arnold signed a definitive agreement to acquire Canyon Bicycles GmbH from TSG Consumer Partners, LP, Roman Arnold and others.

A Look At Groupe Bruxelles Lambert's (EBR:GBLB) CEO Remuneration

Analysts lower EPS estimates to €2.69

Third quarter 2020 earnings released: €0.40 loss per share

New 90-day low: €73.26

New 90-day high - €79.90

Groupe Bruxelles Lambert SA (ENXTBR:GBLB) completed the acquisition of 60% stake in Webhelp SAS from KKR & Co. Inc. (NYSE:KKR), Frédéric Jousset, Olivier Duha and others.

Previsiones de crecimiento de beneficios e ingresos

Previsiones de crecimiento futuro de los analistas

Previsiones de crecimiento de los beneficios por acción

Rentabilidad financiera futura

Descubre empresas en crecimiento